惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Hugging Face - Blog
Hugging Face - Blog
GbyAI
GbyAI
Engineering at Meta
Engineering at Meta
有赞技术团队
有赞技术团队
博
博客园 - 【当耐特】
H
Hackread – Cybersecurity News, Data Breaches, AI and More
WordPress大学
WordPress大学
博
博客园_首页
美
美团技术团队
H
Help Net Security
MongoDB | Blog
MongoDB | Blog
宝玉的分享
宝玉的分享
大猫的无限游戏
大猫的无限游戏
小众软件
小众软件
J
Java Code Geeks
A
About on SuperTechFans
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
IT之家
IT之家
T
The Blog of Author Tim Ferriss
Microsoft Azure Blog
Microsoft Azure Blog
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
B
Blog
雷峰网
雷峰网
爱范儿
爱范儿

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Pfizer Inc. (PFE) Q1 2026 Earnings Call Transcript
2026-05-06 · via All Articles on Seeking Alpha

Pfizer Inc. (PFE) Q1 2026 Earnings Call May 5, 2026 10:00 AM EDT

Company Participants

Francesca DeMartino - Chief Investor Relations Officer
Albert Bourla - Chairman of the Board & CEO
David Denton - Executive VP & CFO
Chris Boshoff - Chief Scientific Officer and President of Research & Development
Alexandre de Germay - Executive VP & Chief International Commercial Officer
Aamir Malik - Executive VP & Chief U.S. Commercial Officer

Conference Call Participants

Vamil Divan - Guggenheim Securities, LLC, Research Division
David Risinger - Leerink Partners LLC, Research Division
Christopher Schott - JPMorgan Chase & Co, Research Division
Kerry Holford - Joh. Berenberg, Gossler & Co. KG, Research Division
Umer Raffat - Evercore ISI Institutional Equities, Research Division
Asad Haider - Goldman Sachs Group, Inc., Research Division
Evan Seigerman - BMO Capital Markets Equity Research
Courtney Breen - Bernstein Institutional Services LLC, Research Division
Louise Chen - Scotiabank Global Banking and Markets, Research Division

Presentation

Operator

Good day, everyone, and welcome to Pfizer's First Quarter 2026 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMartino, Chief Investor Relations Officer and Senior Vice President. Please go ahead, ma'am.

Francesca DeMartino
Chief Investor Relations Officer

Good morning, and welcome to Pfizer's earnings call. I'm Francesca DeMartino, Chief Investor Relations Officer. On behalf of the Pfizer team, thank you for joining us. This call is being made available via audio webcast at pfizer.com. Earlier this morning, we released our results for the first quarter 2026 via press release that is available on our website at pfizer.com.

I'm joined today by Dr. Albert Bourla, our Chairman and CEO; and Dave Denton, our CFO. Albert and Dave have some prepared remarks, and we will then open the call for questions. Members of our leadership team will be available for the Q&A session.

此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。